In the context of triple-negative breast cancer, WWOX inhibits STAT3-dependent tumor cell growth and metastasis by modulating the IL-6/JAK2/STAT3 signaling pathway, leading to the downregulation of p-STAT3 target genes [33]. This evidence concerns the gene STAT3 and triple-negative breast carcinoma.